The Middle East minimally invasive surgery market size was estimated at USD 7.80 Billion in 2025 and is expected to reach USD 13.41 billion by 2033, growing at a CAGR of 7.02% from 2025 to 2033. This growth is driven by the rising prevalence of lifestyle-related diseases, healthcare infrastructure investment, development of medical tourism, increasing adoption of robotic-assisted surgery, and rising demand for bariatric and cosmetic surgery. Countries such as Saudi Arabia, the UAE, and Qatar invest heavily in modern healthcare infrastructure, equipping hospitals with advanced robotic systems and laparoscopic platforms to attract medical tourism and reduce patient outflow abroad. In addition, the region’s young but increasingly urbanized population is contributing to higher demand for elective surgeries, including bariatric and cosmetic procedures, many of which are performed using minimally invasive surgery (MIS) methods.
The minimally invasive surgery (MIS) market in Middle East is expanding steadily, supported by government-led healthcare reforms, rising rates of lifestyle-related diseases, and growing investments in advanced surgical infrastructure. Countries such as Saudi Arabia and the UAE are at the forefront, driven by national health strategies such as Saudi Vision 2030 and the UAE’s Centennial 2071 plan, which emphasize modernizing healthcare delivery and increasing access to advanced technologies. High prevalence of obesity and diabetes in the region is also fueling demand for bariatric and metabolic surgeries, many of which are now performed using laparoscopic and robotic-assisted techniques to minimize recovery times and complications.
In recent years, hospitals in the GCC have also adopted robotic surgery platforms and AI-enabled imaging systems across specialties, including gynecology, cardiothoracic surgery, and bariatrics. In Saudi Arabia, several hospitals have introduced robotic-assisted programs for bariatric and urological procedures. At the same time, the UAE has witnessed rapid uptake of laparoscopic and endoscopic interventions across its major healthcare hubs such as Dubai and Abu Dhabi. In 2023, Saudi surgeons performed landmark robotic heart and liver transplant surgeries-highlighting the region’s growing expertise in complex minimally invasive interventions and positioning the Middle East as an emerging hub for advanced surgical care.
Despite these advances, challenges remain, including shortages of highly trained MIS surgeons and uneven access to advanced facilities outside major urban centers. Governments and healthcare providers are pursuing initiatives such as cross-border collaborations, partnerships with academic institutions, and expansion of training programs for laparoscopic and robotic techniques to bridge this gap. The increasing role of private healthcare providers and the growth of medical tourism, especially in the UAE, are also expected to play a pivotal role in boosting the availability and adoption of MIS across the region in the coming years.
In 2024, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia marked global milestones with the world’s first fully robotic heart transplant performed on a 16-year-old patient, followed by the first robotic-assisted implantation of an artificial heart pump. These achievements underscore the country's leadership in high-complexity MIS and reflect the broader push under Vision 2030 toward medical innovation and specialized surgical care. Further building on this momentum, in July 2025, KFSHRC executed the world’s first robotic-assisted BiVAD (biventricular assist device) implantation, using minimally invasive robotic arms to support a patient with advanced heart failure.
At the same time, neurological innovation is also gaining ground in the region. Cleveland Clinic Abu Dhabi recently became the first in the Middle East and North Africa to use the Artisse Intrasaccular Flow Modulator, a minimally invasive device for treating wide-necked brain aneurysms - a less invasive alternative to traditional open neurosurgery.
This product will be delivered within 1-3 business days.
The minimally invasive surgery (MIS) market in Middle East is expanding steadily, supported by government-led healthcare reforms, rising rates of lifestyle-related diseases, and growing investments in advanced surgical infrastructure. Countries such as Saudi Arabia and the UAE are at the forefront, driven by national health strategies such as Saudi Vision 2030 and the UAE’s Centennial 2071 plan, which emphasize modernizing healthcare delivery and increasing access to advanced technologies. High prevalence of obesity and diabetes in the region is also fueling demand for bariatric and metabolic surgeries, many of which are now performed using laparoscopic and robotic-assisted techniques to minimize recovery times and complications.
In recent years, hospitals in the GCC have also adopted robotic surgery platforms and AI-enabled imaging systems across specialties, including gynecology, cardiothoracic surgery, and bariatrics. In Saudi Arabia, several hospitals have introduced robotic-assisted programs for bariatric and urological procedures. At the same time, the UAE has witnessed rapid uptake of laparoscopic and endoscopic interventions across its major healthcare hubs such as Dubai and Abu Dhabi. In 2023, Saudi surgeons performed landmark robotic heart and liver transplant surgeries-highlighting the region’s growing expertise in complex minimally invasive interventions and positioning the Middle East as an emerging hub for advanced surgical care.
Despite these advances, challenges remain, including shortages of highly trained MIS surgeons and uneven access to advanced facilities outside major urban centers. Governments and healthcare providers are pursuing initiatives such as cross-border collaborations, partnerships with academic institutions, and expansion of training programs for laparoscopic and robotic techniques to bridge this gap. The increasing role of private healthcare providers and the growth of medical tourism, especially in the UAE, are also expected to play a pivotal role in boosting the availability and adoption of MIS across the region in the coming years.
In 2024, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia marked global milestones with the world’s first fully robotic heart transplant performed on a 16-year-old patient, followed by the first robotic-assisted implantation of an artificial heart pump. These achievements underscore the country's leadership in high-complexity MIS and reflect the broader push under Vision 2030 toward medical innovation and specialized surgical care. Further building on this momentum, in July 2025, KFSHRC executed the world’s first robotic-assisted BiVAD (biventricular assist device) implantation, using minimally invasive robotic arms to support a patient with advanced heart failure.
At the same time, neurological innovation is also gaining ground in the region. Cleveland Clinic Abu Dhabi recently became the first in the Middle East and North Africa to use the Artisse Intrasaccular Flow Modulator, a minimally invasive device for treating wide-necked brain aneurysms - a less invasive alternative to traditional open neurosurgery.
Middle East Minimally Invasive Surgery Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Middle East minimally invasive surgery (MIS) market report based on surgical specialty, method, end-use, and country:Surgical Specialty Outlook (Revenue, USD Million, 2021-2033)
- General Surgery
- Gastrointestinal Surgery
- Gynecological Surgery
- Urological Surgery
- Cardiothoracic Surgery
- Orthopedic & Spine Surgery
- Neurosurgery
- Colorectal Surgery
- Bariatric Surgery
- Vascular & Endoscopic Surgery
- Plastic & Reconstructive Surgery
Method Outlook (Revenue, USD Million, 2021-2033)
- Laparoscopic Surgery
- Thoracoscopic Surgery/VATS
- Robotic-assisted Surgery
- Endoscopic Surgery
- Catheter-based/Interventional Procedures
- Others
End-use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Country Outlook (Revenue, USD Million, 2021-2033)
- Middle East
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Middle East Minimally Invasive Surgery (MIS) Market Variables, Trends & Scope
Chapter 4. Middle East Minimally Invasive Surgery (MIS) Market: Surgical Specialty Estimates & Trend Analysis
Chapter 5. Middle East Minimally Invasive Surgery (MIS) Market: Method Estimates & Trend Analysis
Chapter 6. Middle East Minimally Invasive Surgery (MIS) Market: End Use Estimates & Trend Analysis
Chapter 7. Middle East Minimally Invasive Surgery Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this Middle East Minimally Invasive Surgery market report include:- edtronic plc
- ntuitive Surgical
- MR Surgical
- mith & Nephew plc
- enishaw
- obotics Surgical Systems (UAE)
- uris Health
- lympus Corporation
- iemens Healthineers
- orindus Vascular Robotics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | September 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 7.8 Billion |
| Forecasted Market Value ( USD | $ 13.41 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Middle East |
| No. of Companies Mentioned | 11 |
